News Release

TransMedics to Present at the Cowen 40th Annual Health Care Conference

Feb, 20 2020 at 4:05 PM EST

ANDOVER, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming Cowen 40th Annual Health Care Conference in Boston.

TransMedics’ management is scheduled to present on Tuesday, March 3, 2020 at 8:40 a.m. Eastern Time. A live and archived webcast of the event will be available on the “Investors” section of the TransMedics website at www.transmedics.com

About TransMedics Group, Inc.

TransMedics is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Investor Contact:
Brian Johnston
631-807-1986
Investors@transmedics.com

TransMedics_Logo_tagline_RGB.png

Source: TransMedics